期刊文献+

New options for uveitis treatment

New options for uveitis treatment
下载PDF
导出
摘要 Uveitis is one of the most important causes of blindness worldwide.Its etiology and pathogenesis are complicated and have not been well understood.The treatment for uveitis is predominantly based on steroids and immunosuppressants.However,systemic side effects limit their clinical application.With the advancement of molecular biology,some intravitreal implants and biologic agents have been used for the treatment of uveitis.Additionally,novel techniques such as gene therapy and RNA interference are being studied for using as uveitis therapy.This paper reviews recent advances in uveitis treatment. Uveitis is one of the most important causes of blindness worldwide.Its etiology and pathogenesis are complicated and have not been well understood.The treatment for uveitis is predominantly based on steroids and immunosuppressants.However,systemic side effects limit their clinical application.With the advancement of molecular biology,some intravitreal implants and biologic agents have been used for the treatment of uveitis.Additionally,novel techniques such as gene therapy and RNA interference are being studied for using as uveitis therapy.This paper reviews recent advances in uveitis treatment.
出处 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2013年第5期702-707,共6页 国际眼科杂志(英文版)
关键词 UVEITIS intravitreal implants biologic agents gene therapy RNA interference uveitis intravitreal implants biologic agents gene therapy RNA interference
  • 相关文献

参考文献55

  • 1Simon R.J. Taylor,Oren Tomkins-Netzer,Lavnish Joshi,Jiten Morarji,Eibhlin McLoone,Sue Lightman.Dexamethasone Implant in Pediatric Uveitis[J]. Ophthalmology . 2012 (11)
  • 2Miserocchi, E,Modorati, G,Pastore, M R,Bandello, F.Dexamethasone Intravitreal Implant: An Effective Adjunctive Treatment for Recalcitrant Noninfectious Uveitis[J]. Ophthalmologica . 2012 (4)
  • 3Manuel Díaz-Llopis,David Salom,Carmen Garcia-de-Vicu?a,Miguel Cordero-Coma,Gabriela Ortega,Norberto Ortego,Marta Suarez-de-Figueroa,Maria J. Rio-Pardo,Carlos Fernandez-Cid,Alex Fonollosa,Ricardo Blanco,Angel M. Garcia-Aparicio,Jose M. Benitez-del-Castillo,Jose L. Olea,J. Fernando Arevalo.Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients[J]. Ophthalmology . 2012 (8)
  • 4María José Capella,C. Stephen Foster.Long-Term Efficacy and Safety of Infliximab in the Treatment of Beh?et’s Disease[J]. Ocular Immunology and Inflammation . 2012 (3)
  • 5C. J. Chu,S. E. Barker,A. D. Dick,R. R. Ali.Gene Therapy for Noninfectious Uveitis[J]. Ocular Immunology and Inflammation . 2012 (6)
  • 6R. Erckens,R. Mostard,P. Wijnen,J. Schouten,M. Drent.Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis[J]. Graefe’s Archive for Clinical and Experimental Ophthalmology . 2012 (5)
  • 7Lihteh Wu,J. Fernando Arevalo,Erick Hernandez-Bogantes,José Roca.Intravitreal infliximab for refractory pseudophakic cystoid macular edema: results of the Pan-American Collaborative Retina Study Group[J]. International Ophthalmology . 2012 (3)
  • 8Kaisu Kotaniemi,S?il?.Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis[J]. Clinical Ophthalmology . 2011 (default)
  • 9Marc D. de Smet,Simon R.J. Taylor,Bahram Bodaghi,Elisabetta Miserocchi,Philip I. Murray,Uwe Pleyer,Manfred Zierhut,Talin Barisani-Asenbauer,Phuc LeHoang,Sue Lightman.Understanding uveitis: The impact of research on visual outcomes[J]. Progress in Retinal and Eye Research . 2011 (6)
  • 10Elisabetta Miserocchi,Irene Pontikaki,Giulio Modorati,Francesco Bandello,Pier Luigi Meroni,Valeria Gerloni.Rituximab for Uveitis[J]. Ophthalmology . 2011 (1)

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部